CURE Pharmaceutical
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
CURE Pharmaceutical operates as a drug delivery and development company focused on improving the efficacy, safety, and patient experience of medicines through proprietary dosage forms and delivery systems. It maintains a full-service cGMP manufacturing facility and develops and manufactures CureFilm, an oral thin film delivery platform described as among the most advanced in its category. Based in Oxnard, California, the company collaborates with leading pharmaceutical firms to advance a range of products across innovative delivery platforms. Its activities extend into the pharmaceutical cannabis sector, where it has partnerships in the United States, Canada, Israel, and Germany. In 2022 governance changes included the appointment of Rob Davidson as chairman of the board and Rob Costantino to the board and audit committee, with Gerald Bagg also joining the board.